✦ LIBER ✦

The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?

✍ Scribed by Eskazan, Ahmet Emre; Ar, Muhlis Cem; Soysal, Teoman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rebuttal and response to: “The efficacy

✍ Alwan, Alaa Fadhil 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 395 KB

The efficacy of generic formulations of

✍ Eskazan, Ahmet Emre; Elverdi, Tugrul; Yalniz, Fevzi Firat; Salihoglu, Ayse; Ar, 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 107 KB

Efficacy and Safety of Imatinib Mesylate

✍ Yasuo Morishima; Michinori Ogura; Miki Nishimura; Fumiharu Yazaki; Masami Bessho 📂 Article 📅 2004 🏛 Carden Jennings Publishing 🌐 English ⚖ 93 KB

Choosing the best treatment strategy for

✍ Jabbour, E; Hochhaus, A; Cortes, J; La Rosée, P; Kantarjian, H M 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 326 KB

Expenditure and effectiveness of treatme

✍ Chen, W.; Zhu, J.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

Frequency of ABL gene mutations in chron

✍ Marcé, Silvia; Zamora, Lurdes; Cabezón, Marta; Xicoy, Blanca; Boqué, Concha; Fer 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Spanish ⚖ 267 KB